ARID1A and bone osteosarcoma: It has been shown that ARID1A promotes NHEJ activity by facilitating the accumulation of Ku70/Ku80 proteins at DSBs, conferring resistance to UV, ionizing radiation, and cisplatin in lung and bone osteosarcoma cells [28].